We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$116B
AUM Growth
-$14.5B
Cap. Flow
-$18.4B
Cap. Flow %
-15.82%
Top 10 Hldgs %
26.94%
Holding
7,691
New
402
Increased
2,587
Reduced
3,614
Closed
585

Sector Composition

Rank Sector Weight
1 Technology 7.41%
2 Healthcare 5.88%
3 Financials 5.51%
4 Consumer Discretionary 4.79%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGI icon
5451
Commercial Vehicle Group
CVGI
$129M
$59K ﹤0.01%
8,116
-12,100
-60% -$93.2K
GRC icon
5452
Gorman-Rupp
GRC
$2.25B
$59K ﹤0.01%
+1,684
New +$55K
KNDI
5453
Kandi Technologies Group
KNDI
$69.8M
$59K ﹤0.01%
13,701
-1,651
-11% -$8.34K
MGNX icon
5454
MacroGenics
MGNX
$248M
$59K ﹤0.01%
2,870
-12,232
-81% -$276K
MOH icon
5455
PUT
Molina Healthcare
MOH
$10.2B
$59K ﹤0.01%
600
-300
-33% -$26.1K
RDI icon
5456
Reading International Class A
RDI
$34.1M
$59K ﹤0.01%
3,652
-46
-1% -$732
TX icon
5457
CALL
Ternium
TX
$10.5B
$59K ﹤0.01%
1,700
-13,500
-89% -$505K
TBRG
5458
CALL
DELISTED
TruBridge
TBRG
$59K ﹤0.01%
+1,800
New +$56.6K
MDRX
5459
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
$59K ﹤0.01%
4,900
+3,600
+277% +$44.4K
GLF
5460
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$59K ﹤0.01%
+1,773
New +$58.6K
ABEO icon
5461
Abeona Therapeutics
ABEO
$388M
$58K ﹤0.01%
145
-225
-61% -$98.3K
APLS
5462
DELISTED
Apellis Pharmaceuticals
APLS
$58K ﹤0.01%
2,648
+281
+12% +$6.46K
CAC icon
5463
Camden National
CAC
$1B
$58K ﹤0.01%
1,261
-2,092
-62% -$94.7K
CCK icon
5464
CALL
Crown Holdings
CCK
$13.3B
$58K ﹤0.01%
1,300
-8,800
-87% -$412K
EEMV icon
5465
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.53B
$58K ﹤0.01%
1,000
GNTX icon
5466
PUT
Gentex
GNTX
$5.14B
$58K ﹤0.01%
2,500
+2,400
+2,400% +$56.9K
NBN icon
5467
Northeast Bank
NBN
$1.14B
$58K ﹤0.01%
2,680
-1,968
-42% -$42.1K
RDWR icon
5468
CALL
Radware
RDWR
$1.2B
$58K ﹤0.01%
+2,300
New +$53.5K
WRB icon
5469
PUT
W.R. Berkley
WRB
$26.8B
$58K ﹤0.01%
2,700
-7,425
-73% -$165K
ITCI
5470
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$58K ﹤0.01%
3,281
-7,528
-70% -$153K
CBAY
5471
DELISTED
Cymabay Therapeutics
CBAY
$58K ﹤0.01%
4,323
-84,064
-95% -$1.05M
ACGN
5472
DELISTED
Aceragen Inc
ACGN
$58K ﹤0.01%
322
-2,963
-90% -$691K
ATNX
5473
DELISTED
Athenex, Inc. Common Stock
ATNX
$58K ﹤0.01%
154
-142
-48% -$48.6K
HUSN
5474
DELISTED
Hudson Capital Inc. Ordinary Shares
HUSN
$58K ﹤0.01%
1,589
+91
+6% +$4.79K
CLMT icon
5475
CALL
Calumet Specialty Products
CLMT
$3.51B
$57K ﹤0.01%
7,600
-11,900
-61% -$89.4K

Similar funds

Barclays's Q2 2018 Portfolio in Review

As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,614 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in Evergy worth $42M.

  • Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
  • Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
  • Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
  • Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
  • Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
  • Barclays opened 402 new positions and closed 585 in Q2 2018.
  • Barclays's portfolio value fell 11% quarter-over-quarter to $116B.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.